Literature DB >> 10838467

Plasma amino acid profile on nocturnal hemodialysis.

D S Raj1, M Ouwendyk, R Francoeur, A Pierratos.   

Abstract

BACKGROUND/AIMS: The purpose of this study was to examine the effect of nocturnal hemodialysis (NHD) on serum amino acid (AA) profile.
METHODS: In a cross-over trial, we studied the AA profile in 11 patients who were switched from conventional hemodialysis to NHD. Plasma levels of AA were measured at monthly intervals for a period of 1 year.
RESULTS: Concentrations of AA isoleucine, threonine, phenylalanine, valine, glycine, glutamine and taurine increased on switch to NHD. Total AA (2,907.2 +/- 542.2 vs. 3,870.2 +/- 715.2 micromol/l, p = 0.03), essential AA (EAA, 842.2 +/- 259.4 vs. 1,125. 8 +/- 235.3 micromol/l, p = 0.03), nonessential AA (NEAA, 2,307.2 +/- 399.1 vs. 2,879.5 +/- 581.2 micromol/l, p = 0.03), and branched chain AA (315.5 +/- 90.8 vs. 386.0 +/- 114.3 micromol/l, p = 0.05) concentrations were significantly higher on NHD. However, abnormalities in the ratios of EAA/NEAA, valine/glycine and tyrosine/phenylalanine persisted during NHD.
CONCLUSIONS: NHD alleviated some abnormalities in the aminogram of uremia, but other metabolic derangements lingered. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10838467     DOI: 10.1159/000014431

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  5 in total

1.  Reduction of carbamylated albumin by extended hemodialysis.

Authors:  Jeffrey Perl; Sahir Kalim; Ron Wald; Marc B Goldstein; Andrew T Yan; Nazanin Noori; Mercedeh Kiaii; Julia Wenger; Christopher Chan; Ravi I Thadhani; S Ananth Karumanchi; Anders H Berg
Journal:  Hemodial Int       Date:  2016-06-21       Impact factor: 1.812

Review 2.  The advantages and challenges of increasing the duration and frequency of maintenance dialysis sessions.

Authors:  Charles Chazot; Guillaume Jean
Journal:  Nat Clin Pract Nephrol       Date:  2008-11-25

3.  An Enlarged Profile of Uremic Solutes.

Authors:  Hisae Tanaka; Tammy L Sirich; Natalie S Plummer; Daniel S Weaver; Timothy W Meyer
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

4.  Optimized metabolomic approach to identify uremic solutes in plasma of stage 3-4 chronic kidney disease patients.

Authors:  Henricus A M Mutsaers; Udo F H Engelke; Martijn J G Wilmer; Jack F M Wetzels; Ron A Wevers; Lambertus P van den Heuvel; Joost G Hoenderop; Rosalinde Masereeuw
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

5.  The Biology of Veganism: Plasma Metabolomics Analysis Reveals Distinct Profiles of Vegans and Non-Vegetarians in the Adventist Health Study-2 Cohort.

Authors:  Fayth L Miles; Michael J Orlich; Andrew Mashchak; Paulette D Chandler; Johanna W Lampe; Penelope Duerksen-Hughes; Gary E Fraser
Journal:  Nutrients       Date:  2022-02-08       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.